Sfoglia per Autore  

Opzioni
Mostrati risultati da 1 a 20 di 515
Titolo Data di pubblicazione Autori Rivista Serie Titolo libro
Mutational profile in 75 anti-MAG antibody neuropathy patients: clinical and hematological correlations, therapy response and hints on new therapeutic targets. In corso di stampa Alessandro SalvalaggioLivio TrentinChiara Briani + NEUROLOGY® NEUROIMMUNOLOGY & NEUROINFLAMMATION - -
Pro-inflammatory cells sustain leukemic clonal expansion in T-cell large granular lymphocyte leukemia 2024 Gasparini V. R.Teramo A.Calabretto G.Rampazzo E.Carraro S.Trimarco V.Trentin L.Facco M.Zambello R. + HAEMATOLOGICA - -
Ibrutinib as first line therapy in chronic lymphocytic leukemia patients over 80 years old: A retrospective real‐life multicenter Italian cohort 2024 Visentin, AndreaTrentin, Livio + HEMATOLOGICAL ONCOLOGY - -
p66Shc deficiency in CLL cells enhances PD-L1 expression and suppresses immune synapse formation 2024 Frezzato, FedericaVisentin, AndreaTrentin, Livio + FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY - -
Chronic Lymphocytic Leukemia (CLL) with Borderline Immunoglobulin Heavy Chain Mutational Status, a Rare Subgroup of CLL with Variable Disease Course 2024 Pagnin, ElisaFrezzato, FedericaFacco, MonicaPiazza, FrancescoTrentin, LivioVisentin, Andrea + CANCERS - -
Leukemic cell-secreted interleukin-9 suppresses cytotoxic T cell-mediated killing in chronic lymphocytic leukemia 2024 Frezzato, FedericaVisentin, AndreaTrentin, Livio + CELL DEATH & DISEASE - -
Venetoclax infectious risk score to identify patients with chronic lymphocytic leukemia at high infectious risk during venetoclax treatment: A multicenter SEIFEM study 2024 Visentin, AndreaTrentin, Livio + AMERICAN JOURNAL OF HEMATOLOGY - -
How receptor tyrosine kinase‐like orphan receptor 1 meets its partners in chronic lymphocytic leukemia 2024 Ruggeri, EdoardoCapasso, GuidoVisentin, AndreaFrezzato, FedericaTrentin, Livio + HEMATOLOGICAL ONCOLOGY - -
Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital 2023 Scapinello, GretaGrassi, AngelaVisentin, AndreaPavan, LauraManni, SabrinaVianello, FabrizioBriani, ChiaraZambello, RenatoTrentin, LivioPiazza, Francesco + HEMASPHERE - -
Antibody Response to the SARS-CoV-2 Vaccine and COVID-19 Vulnerability during the Omicron Pandemic in Patients with CLL: Two-Year Follow-Up of a Multicenter Study 2023 Visentin, AndreaTrentin, Livio + CANCERS - -
Focal adhesion kinase activation by calcium-dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness 2023 Severin F.Visentin A.Pagnin E.Trimarco V.Pravato S.Facco M.Trentin L.Frezzato F. + BRITISH JOURNAL OF HAEMATOLOGY - -
Is It Still Possible to Think about HSP70 as a Therapeutic Target in Onco-Hematological Diseases? 2023 Mouawad, NaylaCapasso, GuidoSeverin, FilippoVisentin, AndreaFacco, MonicaTrentin, LivioFrezzato, Federica + BIOMOLECULES - -
The added value of karyotype in predicting the need for therapy in chronic lymphocytic leukemia with 13q deletion 2023 Grassi, AngelaVisentin, AndreaFacco, MonicaPagnin, ElisaTrentin, Livio + HEMATOLOGICAL ONCOLOGY - -
Chest pain in cardiac amyloidosis: occurrence, causes and prognostic significance 2023 De Michieli, LauraDe Gaspari, MonicaSinigiani, GiulioVedovelli, LucaSalvalaggio, AlessandroDella Barbera, MilaRizzo, StefaniaPilichou, KalliopiCecchin, DiegoBriani, ChiaraGregori, DarioTarantini, GiuseppeTrentin, LivioBasso, CristinaCorrado, DomenicoIliceto, SabinoPerazzolo Marra, MartinaCipriani, Alberto + INTERNATIONAL JOURNAL OF CARDIOLOGY - -
Tixagevimab/Cilgavimab as pre-exposure prophylaxis against SARS-CoV-2 in patients with hematological malignancies 2023 D’Amore, FabioPavan, LauraPiazza, FrancescoPravato, StefanoScapinello, GretaVianello, FabrizioZambello, RenatoPadoan, AndreaTrentin, LivioVisentin, Andrea + FRONTIERS IN ONCOLOGY - -
BTK and PLCG2 remain unmutated in one-third of patients with CLL relapsing on ibrutinib 2023 Trentin L. + BLOOD ADVANCES - -
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 2023 Trentin, LivioVisentin, AndreaPravato, Stefano + HEMASPHERE - -
The evolving landscape of COVID-19 and post-COVID condition in patients with chronic lymphocytic leukemia: A study by ERIC, the European research initiative on CLL 2023 Visentin, AndreaLivio, Trentin + AMERICAN JOURNAL OF HEMATOLOGY - -
Spontaneous regression in chronic lymphocytic leukaemia. Clinical features of 50 cases from the ERIC registry and review of the literature 2023 Visentin, AndreaTrentin, LivioSemenzato, Gianpietro + BRITISH JOURNAL OF HAEMATOLOGY - -
Efficacy of Front-line Ibrutinib versus Fludarabine, Cyclophosphamide and Rituximab (FCR) in Patients with CLL. A Retrospective Multicenter "Real-World" Study 2023 Visentin, AndreaTrentin, Livio + AMERICAN JOURNAL OF HEMATOLOGY - -
Mostrati risultati da 1 a 20 di 515
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile